Veterinary diagnostics is one of the most consistently growing segments adjacent to human IVD — benefiting from rising pet ownership globally, premiumization of companion animal healthcare, and the expanding application of in-clinic diagnostic platforms in veterinary practice. IDEXX Laboratories dominates the companion animal diagnostics market with its IDEXX CATALYST and ProCyte systems, and the company's installed base of analyzers in veterinary clinics globally provides a powerful reagent rental revenue stream. Zoetis, Heska, and Antech compete in companion animal diagnostics, while bioMérieux, IDEXX, and Neogen lead food safety and agricultural diagnostic testing. The One Health paradigm — recognizing the interconnection between animal, human, and environmental health — is driving investment in zoonotic disease surveillance and antimicrobial resistance monitoring that spans both veterinary and human IVD.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Veterinary Diagnostics Market Size and Forecast 2025-2030 by Segment and Region
• Companion Animal Diagnostics — Chemistry, Hematology, Immunoassay, and Molecular Testing
• In-Clinic Diagnostics — IDEXX CATALYST, ProCyte, and In-House Platform Competition
• Reference Lab Veterinary Testing — IDEXX Reference Laboratories and Antech
• Livestock and Production Animal Diagnostics — Disease Surveillance and AMR Testing
• Food Safety IVD — Pathogen Detection, Mycotoxin, and Residue Testing
• Zoonotic Disease Diagnostics — Rabies, Brucella, Avian Influenza, and Emerging Pathogens
• Competitive Landscape — IDEXX, Zoetis, Heska, bioMérieux, Neogen, and QIAGEN
• Regional Analysis — Companion Animal Ownership and Vet Diagnostic Adoption Globally
• Investment and Partnership Opportunities — In-Clinic Platform and Food Safety Testing
'
Table of Contents
1. Executive Summary
- Key findings and strategic implications
- Highest-priority opportunities
- Competitive landscape summary
- Strategic recommendations
2. Market Overview
- Market definition, scope and segmentation
- Key demand drivers and restraints
- Regulatory environment by segment
3. Companion Animal Diagnostics
- In-clinic diagnostics — IDEXX CATALYST, ProCyte, and competitors
- Reference lab veterinary testing — IDEXX and Antech
- Market dynamics and growth drivers
4. Livestock and Production Animal Diagnostics
- Disease surveillance and vaccination monitoring
- AMR testing in food-producing animals
- Regulatory requirements and export market implications
5. Food Safety IVD
- Pathogen detection — Salmonella, Listeria, and E. coli
- Mycotoxin and residue testing
- Leading suppliers — bioMérieux, IDEXX, and Neogen
6. Zoonotic Disease Diagnostics
- Rabies, brucella, and avian influenza testing
- One Health surveillance programs
- Emerging pathogen detection
7. Competitive Landscape
- IDEXX, Zoetis, Heska, bioMérieux, Neogen, and QIAGEN
- New entrants and platform challengers
- M&A and partnership activity 2023-2025
8. Regional Market Analysis
- 8.1 North America (U.S., Canada, Mexico)
- 8.2 Europe (38 countries)
- 8.3 Asia-Pacific (18 countries)
- 8.4 Latin America (22 countries)
- 8.5 Middle East (11 countries)
- 8.6 Africa and Rest of World
9. Strategic Conclusions and Recommendations
- Highest-priority opportunities by segment and region
- Market entry and expansion strategies
- M&A, partnership and investment priorities
10. Appendix
- Research methodology
- Abbreviations and definitions
- List of tables and figures
List of Tables
Table 1. Companion Animal Diagnostics — Platform Comparison and Leading Suppliers 2025
Table 2. In-Clinic Diagnostics — IDEXX vs. Competitor Platform Comparison 2025
Table 3. Livestock and Production Animal Diagnostics — Application Landscape 2025
Table 4. Food Safety IVD — Application Landscape and Leading Suppliers 2025
Table 5. Zoonotic Disease Diagnostics — Surveillance Programs and Testing Platforms 2025
Table 6. Leading Suppliers and Competitive Positioning — Veterinary Diagnostics 2025
Table 7. M&A and Partnership Activity 2023-2025
Table 8. Regulatory Framework by Segment and Region 2025
Table 9. Investment Opportunity Assessment by Segment
Table 10. Key Risks and Mitigation Strategies
Abbott Diagnostics
Bio-Rad Laboratories
bioMérieux
Danaher (Beckman Coulter, Cepheid, Radiometer)
DiaSorin
Hologic
QuidelOrtho
Roche Diagnostics
Siemens Healthineers
Sysmex
